Degenerative Disease

4

Review clinical trials related to Degenerative Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.

Participants needed: 150
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Aesculap AGUpdated: May 8, 2026Locations: 4
Eligibility criteria

Indication for a primary medial unicompartmental knee endoprosthesis [+10]

Pregnancy [+3]

Status: Recruiting

Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage 2

Two groups of subjects will be constitute: (i) patients with circumscribed brain injury (including stroke, vascular malformations, tumor or circumscribed infectious lesions) or degenerative/developmental disorders and selective cognitive disorders; (ii) healthy control subjects. The objective of this project is to evaluate specific neuropsychological deficits and apply current brain imaging techniques (anatomical, diffusion, functional, magnetic stimulation) to patients suffering from these cognitive deficits due to brain damage, in order to elucidate the brain mechanisms underlying these deficits.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, CaenUpdated: Apr 13, 2026Locations: 1
Eligibility criteria

Age > 17 years [+5]

For healthy volunteers: previous neurological history (except non complicated mi... [+2]

Status: Recruiting

Thoracic-Lumbar Arthrodesis- Implanet Jazz

Establish a data repository of patients who have undergone single, two-, or three-level lumbar instrumented arthrodesis procedures supplemented by the Implanet Jazz System.

Participants needed: 300
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Francis FarhadiUpdated: Oct 27, 2025Locations: 1Duration: 5 Years
Eligibility criteria

Male and female patients, 18 years of age and older [+1]

Individuals who have not yet reached the age of 18.

Status: Not yet recruiting

Rehabilitation Program on Genetic and Degenerative Ataxia

Cerebellar ataxia is a pathology linked to the lesion of the cerebellum or the afferent and/or efferent cerebellar pathways. The aetiology can be an acquired cerebral lesion, following a chemical poisoning or a genetic degenerative lesion (for example : Friedreich's ataxia, spinocerebellar ataxias, etc.). As reported by the latest estimate available, genetic degenerative cerebellar ataxias affect approximately 6,000 patients in France (Orpha.net). Symptoms suffered by ataxic patients are : problems and gait disorders along with difficulties in coordination resulting in ataxia, uncoordinated movements. These symptoms cause a decrease in the quality of life on patients with spinocerebellar ataxia. The symptoms improvement linked to the cerebellar syndrome is based on rehabilitation that can be supplemented by use of technical aids. Current scientific knowledge confirms that intensive rehabilitation by physiotherapy and occupational therapy in patients with degenerative ataxias improves cerebellar symptoms. Nevertheless, the choice rehabilitation technique stay at the appreciation of the therapist. From the observation, the investigators have designed an intensive multidisciplinary rehabilitation program, called PAMPERO, with partner patients member of two genetic degenerative ataxia patient organisations. This 5-weeks program has been used in clinic during 3 years on 28 patients. It appears to be the only one in France. The preliminary results show a positive effect on ataxia symptom. Nevertheless, the duration of the benefice over time and the effect on the quality of life stay unknown. However, the quality of life is mainly affected by the participation restriction due to the risk of falling. The most frequent complaint from partner patient is the diminution of the social interaction resulting of the incapacity to move without risk. The present protocol aimed at evaluating the Rehabilitation Program in collaboration with partner patient on the symptom intensity, activity and quality of life on genetic and degenerative ataxia. This PAMPERO program's effect will be assessed by comparing the difference of Intensity of symptom measured by to Scale for the Assessment and Rating of Ataxia (SARA) at inclusion and 3 months after the end of rehabilitation.

Participants needed: 48
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Hospices Civils de LyonUpdated: Jan 17, 2024Locations: 3
Eligibility criteria

≥ 18 years [+12]